Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors.
Publication
, Journal Article
Lemons, JM; Chmura, SJ; Luke, JJ; Salama, JK; Al-Hallaq, HA
Published in: Int J Radiat Oncol Biol Phys
October 1, 2016
Duke Scholars
Published In
Int J Radiat Oncol Biol Phys
DOI
EISSN
1879-355X
Publication Date
October 1, 2016
Volume
96
Issue
2S
Start / End Page
E631 / E632
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lemons, J. M., Chmura, S. J., Luke, J. J., Salama, J. K., & Al-Hallaq, H. A. (2016). Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors. Int J Radiat Oncol Biol Phys, 96(2S), E631–E632. https://doi.org/10.1016/j.ijrobp.2016.06.2209
Lemons, J. M., S. J. Chmura, J. J. Luke, J. K. Salama, and H. A. Al-Hallaq. “Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): E631–32. https://doi.org/10.1016/j.ijrobp.2016.06.2209.
Lemons JM, Chmura SJ, Luke JJ, Salama JK, Al-Hallaq HA. Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E631–2.
Lemons, J. M., et al. “Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors.” Int J Radiat Oncol Biol Phys, vol. 96, no. 2S, Oct. 2016, pp. E631–32. Pubmed, doi:10.1016/j.ijrobp.2016.06.2209.
Lemons JM, Chmura SJ, Luke JJ, Salama JK, Al-Hallaq HA. Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E631–E632.
Published In
Int J Radiat Oncol Biol Phys
DOI
EISSN
1879-355X
Publication Date
October 1, 2016
Volume
96
Issue
2S
Start / End Page
E631 / E632
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences